source
- Venture investor Redesign Health shifts from studio model to firm amid AI-driven startup boomAI is allowing founders to launch companies faster, challenging traditional venture studios that create ideas internally. Redesign Health, known for its studio approach, is changing its strategy,…
- FDA grants early approval to RevMed's pancreatic cancer drug RasonqueFDA granted early approval to Revolution Medicines' daraxonrasib, now named Rasonque, for pancreatic adenocarcinoma, arriving 6.5 months before the FDA deadline. The oral RAS inhibitor demonstrate…